|本期目录/Table of Contents|

[1]乔天阳,刘文兰,王文娟,等.一贯煎及骨髓间充质干细胞对肝纤维化大鼠阴虚证表征影响的实验研究[J].环球中医药,2017,10(04):419-424.[doi:10.3969/j.issn.1674-1749.2017.04.009]
 QIAO Tianyang,LIU Wenlan,WANG Wenjuan,et al.Experimental study on the effect of Yiguanjian and bone marrow mesenchymal stem cells on the expression of yin deficiency syndrome in rats with hepatic fibrosis[J].,2017,10(04):419-424.[doi:10.3969/j.issn.1674-1749.2017.04.009]
点击复制

一贯煎及骨髓间充质干细胞对肝纤维化大鼠阴虚证表征影响的实验研究()
     
分享到:

《环球中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
第10卷
期数:
2017年04期
页码:
419-424
栏目:
论著
出版日期:
2017-04-06

文章信息/Info

Title:
Experimental study on the effect of Yiguanjian and bone marrow mesenchymal stem cells on the expression of yin deficiency syndrome in rats with hepatic fibrosis
作者:
乔天阳刘文兰王文娟王程孟月
100069 北京,首都医科大学中医药学院[乔天阳(硕士研究生)、刘文兰、王文娟、孟月(硕士研究生)、王程(硕士研究生)]
Author(s):
QIAO TianyangLIU WenlanWANG Wenjuanet al.
School of Traditional Chinese Medicine,Capital Medical University,Beijing 100069,China
关键词:
阴虚证 肝纤维化 一贯煎 骨髓间充质干细胞
Keywords:
Yin deficiency syndrome Liver fibrosis Yiguanjian Bone marrow mesenchymal stem cells
分类号:
R259
DOI:
10.3969/j.issn.1674-1749.2017.04.009
文献标志码:
A
摘要:
目的 观察骨髓间充质干细胞在一贯煎的作用下对肝纤维化大鼠阴虚证的影响并探讨该过程的发生机制。方法 将54只SD大鼠随机分为6组,即正常对照组、模型组、阳性对照组、骨髓干细胞组、骨髓干细胞一贯煎组及一贯煎治疗组。除正常对照组外,其他5组建立CCl4诱导的肝纤维化模型。造模停止第三天,骨髓干细胞组及骨髓干细胞一贯煎组经尾静脉注射骨髓间充质干细胞。一贯煎组及骨髓干细胞一贯煎组给予一贯煎浓缩液灌胃,模型组、正常组灌服生理盐水,阳性组给予秋水仙碱灌胃,每天一次,一共给药4周,给药期间每周测量大鼠体质量、体温、血流速度、饮水量。4周后取材,将pH试纸置于大鼠舌面20秒,测量前后重量变化,判定大鼠舌面干湿度; 通过HE染色和马松染色评价肝脏炎症活动度和纤维化程度; 通过苦味酸—天狼星红染色评判造模大鼠肝组织细胞胶原面积比; 通过荧光示踪评判骨髓间充质干细胞在肝纤维化大鼠肝组织中的表达。结果(1)一贯煎加骨髓间充质干细胞组的炎症活动度和纤维化程度明显低于模型组,差异有统计学意义(P<0.05);(2)肝纤维化大鼠有阴虚证的表征,一贯煎和骨髓间充质干细胞可以改善大鼠阴虚证的症状。(3)中药组、骨髓间充质干细胞组、中药加骨髓间充质干细胞组和阳性组体重增长均明显高于模型组(P<0.05); 一贯煎加骨髓间充质干细胞组大鼠舌重较骨髓间充质干细胞组较模型组增高(P<0.05); 模型组舌面温度为较正常组明显增高(P<0.05); 一贯煎加骨髓间充质干细胞组与模型组相比较明显降低(P<0.05); 一贯煎加骨髓间充质干细胞组舌血流速度与模型组相比较降低更为明显(P<0.05); 一贯煎加骨髓间充质干细胞组大鼠饮水量与模型组相比较明显降低(P<0.05)。(4)一贯煎组、阳性对照组、骨髓间充质干细胞组和一贯煎加骨髓间充质干细胞组的胶原面积比明显低于模型组(P<0.05)。(5)一贯煎加骨髓间充质干细胞组的骨髓间充质干细胞荧光面积与骨髓间充质干细胞组相比较明显增高(P<0.05)。结论 骨髓间充质干细胞可以改善肝纤维化大鼠的阴虚证表征,而一贯煎通过促进骨髓间充质干细胞向肝组织转移而增强骨髓间充质干细胞对肝纤维化大鼠阴虚证表征的改善作用。
Abstract:
Objective To observe the effect of Yiguanjian on bone marrow mesenchymal stem cells on the yin deficiency syndrome in rats with liver fibrosis, and to explore the mechanism of the process.Methods 54 male Sprague-Dawlay rats were divided into normal group, model group, positive group, bone marrow mesenchymal stem cells group, Yiguanjian and bone marrow mesenchymal stem cells group and Yiguanjian group. In addition to the normal group, hepatic fibrosis model was induced by CCl4. After third day of modeling, bone marrow stem cells group and Yiguanjian and bone marrow stem cells group was injected with bone marrow mesenchymal stem cells. Yiguanjian group and Yiguanjian and bone marrow stem cells group was intragastric administration with Yiguanjian(2 mL/200 g),1 time/d. Model group and normal group was intragastric administration with normal saline. Positive group was intragastric administration with colchicine. The weight changes before and after was measured to determine the humidity of rat tongue. The body weight, temperature, amount of blood flow velocity, water intake was measured of rats weekly. After 4 weeks, the pH test strips was put at the rat tongue for 20 seconds; HE staining staining was used to evaluate the activity of liver inflammation and the degree of fibrosis; picric acid - Sirius red staining was used to evaluate area ratio of liver tissue collagen; fluorescence tracer was used to evaluate the expression of bone marrow mesenchymal stem cells in rat liver tissue. Results(1)Compared with the model group, the inflammatory activity and the degree of fibrosis was significantly lower than the Yiguanjian and bone marrow mesenchymal stem cells group. The difference was statistically significant(P<0.05).(2)The liver fibrosis rats had characterization of yin deficiency syndrome, Yiguanjian and bone marrow mesenchymal stem cells can improve the symptoms of yin deficiency syndrome.(3)Weight gain of Yiguanjian group, bone marrow mesenchymal stem cells group, Yiguanjian combined with bone marrow mesenchymal stem cells group and positive group was significantly higher than that of model group(P<0.05); Yiguanjian combined with bone marrow mesenchymal stem cells in rats with tongue bone marrow mesenchymal stem cells group was higher than that of model group(P<0.05); the temperature on the surface of tongue of model group was significantly higher than the normal group(P<0.05). Compared with the model group, the Yiguanjian and bone marrow mesenchymal stem cells(MSCs)were significantly lower(P<0.05); blood flow velocity of tongue of Yiguanjian and bone marrow mesenchymal stem cells group was decreased significantly compared with the model group(P<0.05); water intake of Yiguanjian and bone marrow mesenchymal stem cells group was significantly decreased compared with the model group(P<0.05).(4)Area ratio of liver tissue collagen of Yiguanjian group, positive control group, the bone marrow mesenchymal stem cells group and Yiguanjian and bone marrow mesenchymal stem cells groups was significantly lower than that of the model group(P<0.05).(5)Fluorescent area of mesenchymal stem cells of Yiguanjian and bone marrow mesenchymal stem cells group was increased significantly compared with bone marrow mesenchymal stem cells group(P<0.05). Conclusion Bone marrow mesenchymal stem cells can improve the characteristic of yin deficiency syndrome of liver fibrosis in rats, and Yiguanjian can promote bone marrow mesenchymal stem cells transfer into liver to improve the syndrome of yin deficiency in rats with hepatic fibrosis

参考文献/References:

[1] 中国中西医结合学会肝病专业委员会. 肝纤维化中西医结合诊疗指南[J]. 中华肝脏病杂志, 2006, 16(11):260-264.
[2] 岳煜, 薛博瑜. 肝纤维化中医药研究进展[J]. 中医学报, 2010, 25(6):1243-1245.
[3] 刘文兰, 油红捷, 赵青舟,等. 肝纤维化大鼠阴虚证表征的观察及一贯煎的干预作用[J]. 中国医药导报, 2015,(7):7-10.
[4] 刘文兰, 油红捷, 车念聪,等. 一贯煎促进骨髓间充质干细胞逆转肝纤维化的实验研究[J]. 环球中医药, 2014,(6):401-405.
[5] 林志健, 张冰, 刘小青,等. 中医证候动物模型评价研究[J]. 中华中医药杂志, 2013,(8):2217-2221.
[6] 李晓红, 杨力强. 中医证候动物模型研究述评[J]. 广西中医药大学学报, 2012, 15(1):78-80.
[7] 魏盛, 孙鹏, 张惠云. 证候动物模型质量考核的思路与方法[J]. 中华中医药杂志, 2012, 27(10):2607-2610.
[8] 张建军, 李艳霞, 王景霞,等. 辐照结合束缚应激致血虚肝郁大鼠证候模型的建立[J]. 中华中医药杂志, 2014,(7):2176-2179.
[9] 林志健, 张冰, 刘小青,等. 中医证候动物模型评价研究[J]. 中华中医药杂志, 2013,(8):2217-2221.
[10] 王磊, 李宗帅, 张海蓉. 骨髓间充质干细胞在肝硬化治疗中的研究进展[J]. 世界华人消化杂志, 2015,(28):4522-4528.
[11] Kumar M, Sarin S K. Is cirrhosis of the liver reversible?[J]. The Indian Journal of Pediatrics, 2007, 74(4):393-399.
[12] 闫晓风, 叶目亭杰, 刘会洋,等. 骨髓间充质干细胞向肌成纤维细胞转化及一贯煎的影响[J]. 中国实验方剂学杂志, 2011, 17(22):123-126.
[13] Higashiyama R, Inagaki Y, Hong Y Y, et al. Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice.[J]. Hepatology, 2007, 45(1):213-222.
[14] 王晓柠, 陶庆, 冯琴,等. 一贯煎对CCl4诱导的肝纤维化大鼠肝组织胶原代谢的影响[J]. Journal of Integrative Medicine, 2011, 9(6):651-657.
[15] 王昆, 王凤洲, 褚春薇,等. 一贯煎加味抗肝纤维化的实验性研究[J]. 贵阳中医学院学报, 2006, 28(1):61-63.

相似文献/References:

[1]靳士晓,李仙义,付珊珊,等.鳖甲抗肝纤维化药效物质基础及质量控制研究思路[J].环球中医药,2012,5(06):433.
[2]钟锐.柴芍六君子汤加减方治疗肝纤维化60例[J].环球中医药,2012,5(06):453.
[3]柴宁莉,徐世平,石卉,等.精氨酸-甘氨酸-天冬氨酸对氧化苦参碱脂质体减轻肝纤维化的增强作用研究[J].环球中医药,2012,5(09):645.
 CHAI Ning li,X Shi ping,SHI Hui,et al.ArginineGlycinAspartic acid could enhance oxymatrine liposomes theraputic effect on hepatic fibrosis[J].,2012,5(04):645.
[4]李川,吕文良,陈兰羽,等.单味中药抗肝纤维化机制研究概述[J].环球中医药,2012,5(10):789.
 LI Chuan,LYU Wen liang,CHEN Lan yu,et al.Mechanism research of single Chinese herb antifibrotic[J].,2012,5(04):789.
[5]陆云飞,陈晓蓉,刘成,等.复方芪术汤对四氯化碳致大鼠肝纤维化的影响研究[J].环球中医药,2012,5(05):346.
 LU Yun fei,CHEN Xiao rong,LIU Cheng..Therapeutic effects of Compound Qizhu Decoction on carbon tetrachloride (CCl4)induced liver fibrosis in rats[J].,2012,5(04):346.
[6]白辰 车念聪 刘文兰 赵晖 司远.一贯煎汤剂对肝纤维化大鼠肝脏I 型胶原摇的影响[J].环球中医药,2015,8(08):901.[doi:doi:10.3969/j.issn.1674-1749.2015.08.002]
 BAI Chen,CHE Nian-cong,LIU Wen-lan,et al.Influence of Yiguanjian decoction on type I collagen in liver of rats with hepatic fibrosis[J].,2015,8(04):901.[doi:doi:10.3969/j.issn.1674-1749.2015.08.002]
[7]徐筱青 张培彤.阴虚证诊断标准及其量化方法研究概述[J].环球中医药,2017,10(03):368.[doi:10.3969/j.issn.1674-1749.2017.03.035]
 XU Xiaoqing,ZHANG Peitong..Summarization of diagnostic criterion and quantitative method of yin-deficiency syndrome[J].,2017,10(04):368.[doi:10.3969/j.issn.1674-1749.2017.03.035]
[8]倪瑶 吕文良 李娟梅 张婷婷.粉防己碱防治肝纤维化的作用机制研究[J].环球中医药,2017,10(08):922.[doi:10.3969/j.issn.1674-1749.2017.08.038]
 NI Yao,LV Wenliang,LI Juanmei,et al.Research progress on the mechanism of tetrandrine in preventing and treating liver fibrosis[J].,2017,10(04):922.[doi:10.3969/j.issn.1674-1749.2017.08.038]
[9]刘兴,侯云霞,张红艳.化瘀软坚汤联合替诺福韦治疗慢性乙肝肝纤维化63例[J].环球中医药,2017,10(12):1534.[doi:10.3969/j.issn.1674-1749.2017.12.036]

备注/Memo

备注/Memo:
基金项目: 国家自然科学基金(81573879); 首都中医药研究专项重点课题(15ZY03)
作者简介: 乔天阳(1991- ),女,2014级在读硕士研究生。研究方向:肝纤维化中医证候病理的研究。E-mail:qiao.tianyang@163.com
通信作者: 刘文兰(1968- ),女,博士,副教授,硕士生导师。研究方向:慢性肝炎中医证候病理基础的研究。E-mail:wenlanliu1900@126.com
更新日期/Last Update: 2017-04-06